Concepedia

Richard Petrucci

RP

7

Publications

865

Citations

7

H-Index

1980

Active since

Affiliations

MannKind Corporation (United States)(Current)

Dallas Diabetes Research Center

Tufts University

Richard Petrucci is an author at MannKind Corporation (United States) specializing in medicine, drug resistance, and biochemistry.

Top concepts

Publications per year

1980–2012

7

Publications

7

Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.

Laura M. McMurry, Richard Petrucci, Stuart B. Levy · Proceedings of the National Academy of Sciences · 1980 · 595 citations · Full text

, , +14

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

Julio Rosenstock, Daniel L. Lorber, Luigi Gnudi et al. · The Lancet · 2010 · 126 citations

, , +7

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

Julio Rosenstock, Richard M. Bergenstal, Ralph A. DeFronzo et al. · Diabetes Care · 2008 · 52 citations · Full text

Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli

Laura M. McMurry, J C Cullinane, Richard Petrucci et al. · Antimicrobial Agents and Chemotherapy · 1981 · 37 citations · Full text

, , +17

Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabetes

Cees J. Tack, V. Christov, Bastiaan E. de Galan et al. · Journal of Diabetes Science and Technology · 2008 · 24 citations · Full text

Rows per page

1–5 of 7